source
- Veradermics keeps ‘momentum going’ as baldness drug helps women with hair lossThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.BioPharma Dive · 14d ago↗ source
- Kelun pads efficacy profile of Merck-partnered ADC; Europe will have to wait for Boehringer's HernexeosPlus, news about Vogenx and Orakl Oncology. 🇨🇳 Kelun touts China data for sac-TMT: Kelun-Biotech announced on Tuesday that its Merck-partnered antibody-drug conjugate sacituzumab tirumotecan succ…Endpoints · 14d ago↗ source
- STAT+: Brain implant restores the sensation of touch in a person with quadriplegiaA brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.